The company says that many scientists now support the notion that controlling the oxidation of LDL cholesterol is essential for maintaining arterial health.
On April 12 during the SupplySide Science Tour being held in Salt Lake City, UT, Stratum Nutrition’s (St. Louis) manager of pharmacology Joseph L. Evans, PhD, will present information on arterial-health ingredient Artinia.
Titled “Effects of Artinia in Cardiohealth: Oxidized LDL as a Biomarker,” the presentation will cover the benefits of Artinia, which combines soluble and insoluble fibers and supports healthy arteries and overall cardiovascular health.
The company says that many scientists now support the notion that controlling the oxidation of low-density lipoprotein (LDL) cholesterol, and not just the level of LDL cholesterol, is essential for maintaining arterial health. This is because the oxidation of LDL cholesterol within the artery wall leads to a series of inflammatory events that can result in the formation of fatty streaks in the artery tissue, which in time can turn into arterial plaque.
Artinia works as an antioxidant, resulting in a reduced level of oxidized LDL. The ingredient is GRAS affirmed and approved by the EU Commission as a Novel Food ingredient. It is vegetarian and gluten free.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.